Abstract: Single-cell RNA sequencing (scRNA-seq) is a potent advancement for analyzing gene expression at the individual cell level, allowing for the identification of cellular heterogeneity and ...
Abstract: The design of controllers from data for nonlinear systems is a challenging problem. In a recent paper, De Persis, Rotulo and Tesi, “Learning controllers from data via approximate ...
CDKN2A is one of the body’s most important natural defenses against cancer. Often called the “cell cycle brake,” this gene tells cells when to stop dividing and helps damaged cells self-destruct. In ...
New preclinical findings highlight Telomir-1’s ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene – often called the body’s natural “cell cycle brake.” These results ...
🐛 BugAnt Design Team had proved that this is a bug.Ant Design Team had proved that this is a bug.👷🏻♂️ Someone working on it There was no such issue on 5.27.2 - there was other issue with ...
Hanif Mouehla (right) with his mentor and transplant surgeon, Dr. Mitchell Cairo. Florida leads the nation in people living with sickle cell disease, which disproportionately affects the Black ...
Designation supports the potential of olomorasib plus Keytruda to address unmet needs in the first-line treatment of patients with KRAS G12C-mutant non-small lung cancer with high PD-L1 expression.
REDMOND, Wash., Sept. 2, 2025 /PRNewswire/ -- SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced that two abstracts for iza-bren (izalontamab brengitecan), a ...
The inference of cell-cell communication (CCC) is crucial for a better understanding of complex cellular behavior and regulatory mechanisms in biological systems. However, current computational ...
For life to function, cell membranes must remain intact. When these fragile barriers are damaged – for instance by heat or viral attack – specialized proteins come to the rescue. Researchers at ...
CHICAGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results